SWEDISH ORPHAN BIOVITRUM AB (PUBL)

(SOBI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Stock Pick
Swedish Orphan Biovitrum AB (publ) : Consistent Growth, Surprisingly Affordable Valuation
SOBI, still valued at less than 20 times its expected profit for 2019 - a valuation that is surprisingly affordable in a market that is this expensive - remains one of the most promising European pharmaceutical companies.
More Recommendations
Upcoming event on SWEDISH ORPHAN BIOVITRUM AB (PUBL)